State health plan overseers voted Thursday to eliminate coverage for GLP-1 drugs for obesity, capping off months of torn decision-making over how to tamp down surging health care costs while maintaining care access for members
[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Bagga P., Hariharan H., Wilson N.E., Beer J.C., Shinohara R.T., Elliott M.A., Baur J.A., Marincola F.M., Witschey W.R., Haris M., et al
Assign a dedicated staff member for authorizations and offer telehealth for more flexibility
By framing results within a clinically guided timeline, MEDVi positions semaglutide as a long-term metabolic support tool rather than a rapid intervention
Storage: 2-8C (refrigerate after reconstitution)
Following a 2-month washout period, the mean MDS-UPDRS motor scores in the off-medication state were 2.9 points higher in the placebo group, underscoring the potential benefits of lixisenatide in early PD [100]